CRIS Current Research Information System

COLECCHIA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.642
AS - Asia 6.197
EU - Europa 5.117
AF - Africa 403
SA - Sud America 349
Continente sconosciuto - Info sul continente non disponibili 338
OC - Oceania 8
Totale 21.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.524
VN - Vietnam 1.822
SG - Singapore 1.606
CN - Cina 1.519
GB - Regno Unito 1.446
IT - Italia 744
DE - Germania 638
SE - Svezia 590
FR - Francia 372
HK - Hong Kong 372
IN - India 327
RU - Federazione Russa 285
UA - Ucraina 260
BR - Brasile 215
IE - Irlanda 195
ZA - Sudafrica 133
NL - Olanda 123
EE - Estonia 115
JP - Giappone 111
CH - Svizzera 103
CI - Costa d'Avorio 102
BD - Bangladesh 77
TG - Togo 65
CA - Canada 59
FI - Finlandia 59
JO - Giordania 57
AR - Argentina 49
PH - Filippine 48
KR - Corea 47
NG - Nigeria 39
TH - Thailandia 37
BG - Bulgaria 36
SC - Seychelles 35
EC - Ecuador 30
PL - Polonia 29
TR - Turchia 26
BE - Belgio 25
TW - Taiwan 24
GR - Grecia 23
MX - Messico 22
ES - Italia 21
CO - Colombia 17
ID - Indonesia 17
IR - Iran 16
PK - Pakistan 14
LB - Libano 13
IQ - Iraq 12
LT - Lituania 11
SA - Arabia Saudita 11
VE - Venezuela 10
CL - Cile 8
HR - Croazia 8
JM - Giamaica 8
MY - Malesia 8
PE - Perù 8
UZ - Uzbekistan 8
AU - Australia 6
HN - Honduras 6
KE - Kenya 6
AT - Austria 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
ET - Etiopia 5
IL - Israele 5
NI - Nicaragua 5
PY - Paraguay 5
BO - Bolivia 4
EG - Egitto 4
AL - Albania 3
AO - Angola 3
DK - Danimarca 3
MD - Moldavia 3
NP - Nepal 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
EU - Europa 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MM - Myanmar 2
MT - Malta 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
RO - Romania 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
Totale 20.702
Salva come PNG Salva come JPEG
Città #
Southend 1.308
Singapore 1.079
Fairfield 942
Ashburn 838
Chandler 606
Woodbridge 397
San Jose 393
Houston 375
Seattle 374
Wilmington 368
Santa Clara 361
Hong Kong 343
Ho Chi Minh City 337
Dong Ket 317
Hanoi 292
Cambridge 290
Ann Arbor 276
Princeton 266
Beijing 219
Dublin 194
Boardman 167
Jacksonville 156
Nanjing 137
Bologna 131
Lauterbourg 128
Westminster 127
Council Bluffs 125
Padova 119
Los Angeles 114
Hefei 111
Abidjan 102
Tokyo 98
New York 95
Bern 86
Frankfurt am Main 74
Dallas 72
Berlin 66
Lomé 65
Buffalo 62
Saint Petersburg 62
Da Nang 59
San Diego 59
Amman 57
Medford 57
Shenyang 57
Milan 56
Haiphong 52
Dearborn 51
Jinan 48
Helsinki 47
Abeokuta 39
Changsha 37
Hebei 37
Shanghai 36
Seoul 34
Guangzhou 33
Nanchang 33
Sofia 33
Tianjin 33
Turin 33
São Paulo 31
Bremen 30
Phoenix 30
Munich 29
Redondo Beach 29
Jiaxing 27
Florence 25
Mülheim 25
Chicago 24
Orem 24
Brussels 22
Redwood City 22
Biên Hòa 21
Falkenstein 21
Hangzhou 21
Mahé 20
Yubileyny 20
Hải Dương 19
Des Moines 18
Norwalk 18
Rome 18
Toronto 18
Kuban 17
Ningbo 17
Falls Church 16
Guayaquil 16
Mountain View 16
Xi'an 16
Bangkok 15
Brooklyn 15
London 15
Pune 15
Wuhan 15
Can Tho 14
Atlanta 13
Haikou 13
San Francisco 13
Shenzhen 13
Zhengzhou 13
Fuzhou 12
Totale 13.339
Salva come PNG Salva come JPEG
Nome #
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 335
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 305
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 294
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 281
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 259
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 249
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 240
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 231
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 225
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 225
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 224
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 223
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 221
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 220
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 218
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 217
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 214
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 210
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 210
Benign hepatic nodular lesions after treatment for childhood cancer 205
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 205
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 204
H 2breath testing for other gas-related syndromes 200
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 198
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 197
Gut Microbiota and Celiac Disease 196
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 194
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 194
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 189
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 184
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 183
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 182
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 180
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 180
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 180
Pharmacological modulation of MRP2 in primary biliary cirrhosis 179
null 179
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 178
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 177
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 177
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 177
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 173
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 172
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 172
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 170
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 169
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 169
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 166
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 166
Biliary symptoms, gallbladder motility, and cholecystectomy 164
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 164
Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome 164
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 164
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 163
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 163
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 162
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 162
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 161
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 160
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. 158
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 157
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 156
Gut microbiota and metabolic syndrome. 156
Calcolosi della colecisti complicata 155
Serum TUDCA/UDCA concentration profiles after TUDCA oral load: A new test for intestinal transit time and bacteria overgrowth evaluation 154
Breath tests with stable isotopes: have they a role in liver transplantation? 154
Management of hepatic encephalopathy: focus on antibiotic therapy 154
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 153
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. 153
Prognostic factors for hepatocellular carcinoma recurrence 153
Safety of interferon beta treatment for chronic HCV hepatitis. 152
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation variant. Result of an open, uncontrolled , multicenter trial. 152
Ecosistema intestinale: aspetti fisiopatologici e terapeutici 152
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 151
Gut microbiota and its pathophysiology in disease paradigms. 151
Salivary TUDCA concentration profiles after TUDCA oral load: a non-invasive test for intestinal transit time evaluation 149
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 149
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 148
UDCA UP-REGULATES HUMAN PLACENTAL BCRP EXPRESSION: PRELIMINARY RESULTS 148
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 148
Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: A case report 147
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 147
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 147
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 147
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 145
Bacteria flora,gas and antibiotics 144
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 142
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, costipation-variant: results of a multicenter trial 141
Italian consensus conference for colonic diverticulosis and diverticular disease 140
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 140
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study 135
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 135
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 134
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 134
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 132
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 131
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 130
Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease 129
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 129
Modulation of placental bilirubin and bile acids transporters during cholestasis of pregnancy. 129
Totale 17.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.276
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.223 0 0 139 156 211 143 60 119 88 149 771 387
2022/20232.529 286 355 158 324 162 195 52 134 454 61 176 172
2023/2024640 38 114 38 72 43 150 23 51 35 31 22 23
2024/20252.451 94 450 223 158 481 127 144 56 33 184 59 442
2025/20265.538 362 414 475 389 599 333 697 123 1.333 446 201 166
2026/2027500 107 162 231 0 0 0 0 0 0 0 0 0
Totale 21.054